Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low
The investment will increase SpeeDx internal capacity to scale up manufacturing
Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug
The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
Subscribe To Our Newsletter & Stay Updated
